A comprehensive view of Smith & Nephew PLC. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Tissue & Hygiene Market Intelligence Service.

Recent Articles

sample of recent headlines, press releases and get more..

Smith+Nephew reports Q1 revenue up 3.3% year-over-year to US$1.3B driven by strong performance from sports medicine, ENT, advanced wound management, improvements in orthopedics; established markets up 4.1% as elective surgery volumes recover from COVID-19

Smith & Nephew issued patent for self-contained wound dressing with micropump; dressing comprises nonwoven fabrics, super absorbent polymers and apparatus draws wound fluids into a vacuum zone of dressing to facilitate wound healing: USPTO 11278658

Smith+Nephew GRAFIX placental membranes cut diabetic foot ulcer recurrence rates in half compared to cellular, tissue-based products; every year DFUs affect 3 million people in US, with Medicare spending US$6B to US$18B annually for treatment: study

Smith+Nephew shows sports medicine products at AAOS 2022 Meeting in Chicago on Mar. 22-26; exhibits include FAST-FIX Flex meniscal repair system, INTELLIO connected surgical tower, WEREWOLF FASTSEAL 6.0 hemostasis wand, REGENETEN bioinductive implant

Smith+Nephew shows new cementless knee, total hip arthroplasty, robotics products at AAOS 2022 Annual Meeting in Chicago on Mar. 22-26; Smith+Nephew only company in US with cementless products for total knee, partial knee replacement

Ask us about our Tissue & Hygiene market view

Trending Chart

Interactive chart with headline count